A guide to neuromodulation in drug‐resistant epilepsy
Epileptic Disorders · 2026-08 · 28 (4) · 953-980
DOI: 10.1002/epd2.70221 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epileptic Disorders, online erschienen am 27.03.2026. Verfasst von Prachi Parikh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Deep Brain Stimulation, Vagus Nerve Stimulation, Electric Stimulation Therapy. Die Arbeit nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Neuromodulation is approved for the treatment of drug‐resistant epilepsy. It has been increasingly utilized over the past two decades with the approval of deep brain stimulation (DBS) and responsive neurostimulation (RNS) in addition to vagus nerve stimulation (VNS)—particularly in patients who are not deemed to be good resective surgical candidates or in case of patient preference. In this seminar in epileptology article, we address learning objective 3.7 “Demonstrate knowledge of indications, limitations and risks for vagal nerve stimulation and other neuromodulation techniques” of the International League Against Epilepsy curriculum for epileptologists. We will review the indications for neuromodulation, device programming, surgical considerations for implantation, side effects, effects on sleep, and mood. This is complemented by case examples that provide perspective for trainees, along with an outlook on future directions for neuromodulation in epilepsy. This article aims to serve as a learning resource for trainees in neurology, clinical neurophysiology, and epileptology by providing guidance in how to navigate the landscape of neuromodulation in epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
- Brno Epilepsy Center, Member of European Reference Network (ERN) - EpiCARE, The First Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
- Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
- Swiss Epilepsy Center, Klinik Lengg, Zurich, Switzerland.
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Epileptology and Cerebral Rhythmology, APHM, Timone Hospital, Marseille, France.
ORCID-Profile: Birgit Frauscher
Zitieren
APA
Parikh, P., Dolezawa, I., Hegde, M., Imbach, L., Lundstrom, B. N., Pizzo, F., Rao, V. R., Singh, J., Southwell, D., Watanabe, S., & Frauscher, B. (2026). A guide to neuromodulation in drug‐resistant epilepsy. Epileptic Disorders, 28(4), 953-980. https://doi.org/10.1002/epd2.70221
Vancouver
Parikh P, Dolezawa I, Hegde M, Imbach L, Lundstrom BN, Pizzo F, et al. A guide to neuromodulation in drug‐resistant epilepsy. Epileptic Disorders. 2026;28(4):953-980. doi:10.1002/epd2.70221
BibTeX
@article{Parikh2026,
author = {Parikh, Prachi and Dolezawa, Irena and Hegde, Manu and Imbach, Lukas and Lundstrom, Brian N and Pizzo, Francesca and Rao, Vikram R and Singh, Jaysingh and Southwell, Derek and Watanabe, Satsuke and Frauscher, Birgit},
title = {A guide to neuromodulation in drug‐resistant epilepsy},
journal = {Epileptic Disorders},
year = {2026},
volume = {28},
number = {4},
pages = {953--980},
doi = {10.1002/epd2.70221}
}
EUVIMED